Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, United States Department of Agriculture-Agricultural Research Service, University of Missouri-Columbia, University of Alberta, Affymetrix

Illumina this week launched the Infinium BovineSNP50 BeadChip, a 12-sample genotyping product for detecting genetic variation in any breed of cattle.
The chip features more than 54,000 SNPs evenly spaced across the bovine genome, including 24,000 SNPs discovered by using Illumina's next-gen sequencing tool, the Genome Analyzer.
According to Illumina, the BovineSNP50 was developed with researchers from the United States Department of Agriculture-Agricultural Research Service, the University of Missouri-Columbia, the University of Alberta, and other industry partners.
The BovineSNP50 will benefit the bovine research community by offering a more efficient and cost effective method for breeding offspring with desired traits, the firm said.

Affymetrix this week launched the MyGeneChip Program, which it advertises as offering a “complete” line of custom gene expression and genotyping arrays for plant and animal genomes.
Under the new program, Affy said it will work with agricultural, microbial, pharmaceutical and other researchers to design and create reproducible and affordable GeneChip arrays.
Users will be able to perform whole-transcript gene expression, alternative splicing, ChIP-on-chip and transcript mapping experiments using the service, Affy said.
In addition, the MyGeneChip Program will also offer select custom genotyping arrays for plant and animal genomes to help research communities improve the health and nutritional value of plants and animals These custom arrays will be based on the design of the Human SNP Array 6.0, Affy’s 1.8 million feature genotyping array.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.